Rubor, calor, dolor, tumor : infections de la peau et des tissus mous [Rubor, calor, dolor, tumor : skin and soft tissue infections]
Détails
Télécharger: RMS_690_732.pdf (14371.82 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_D43F306B1188
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Rubor, calor, dolor, tumor : infections de la peau et des tissus mous [Rubor, calor, dolor, tumor : skin and soft tissue infections]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
15/04/2020
Peer-reviewed
Oui
Volume
16
Numéro
690
Pages
732-738
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Skin infections are a frequent cause of consultation, yet the diagnosis can be challenging for physicians. Microbiological documentation is rare, and empiric antibiotic regimens should cover the most commonly identified bacteria, i.e. streptococci Staphylococcus aureus. Other pathogens should be considered in case of immunosuppression or certain exposures. Necrotizing fasciitis (NF) is a severe but rare infection. Early surgical management in parallel with antibiotics is the cornerstone of treatment. Despite the high incidence of these infections, little progress has been made in their management and some areas of uncertainty exist, especially regarding the optimal duration of treatment, the prevention of recurrences and the use of polyclonal immunoglobulins for NF. This article reviews the main aspects of diagnosis and treatment of these infections.
Mots-clé
Anti-Bacterial Agents/therapeutic use, Fasciitis, Necrotizing/drug therapy, Fasciitis, Necrotizing/microbiology, Humans, Immunoglobulins/therapeutic use, Skin Diseases, Infectious/diagnosis, Skin Diseases, Infectious/microbiology, Skin Diseases, Infectious/surgery, Skin Diseases, Infectious/therapy, Soft Tissue Infections/diagnosis, Soft Tissue Infections/microbiology, Soft Tissue Infections/surgery, Soft Tissue Infections/therapy, Staphylococcal Infections/drug therapy, Staphylococcal Infections/microbiology, Staphylococcus aureus/drug effects
Pubmed
Site de l'éditeur
Open Access
Oui
Création de la notice
25/04/2020 18:51
Dernière modification de la notice
21/11/2022 8:12